Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Literature DB >> 29551455

A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Samaresh Sau¹, Katyayani Tatiparti², Hashem O Alsaab³, Sushil K Kashaw⁴, Arun K Iyer⁵.

Abstract

Nanoparticle library engineered with tunable size, shape, and geometry will provide a better idea of targeting multicomponent of tumor microenvironment consisting of epithelial cells, tumor hypoxia, tumor immune cells and angiogenic blood vessels.

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2018 PMID： 29551455 PMCID： PMC6046265 DOI： 10.1016/j.drudis.2018.03.003

Source DB: PubMed Journal: Drug Discov Today ISSN： 1359-6446 Impact factor: 7.851

107 in total

Review 1. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.

Authors: Shardool Jain; Aatman S Doshi; Arun K Iyer; Mansoor M Amiji
Journal: J Drug Target Date: 2013-09-12 Impact factor: 5.121

2. Shape effects of filaments versus spherical particles in flow and drug delivery.

Authors: Yan Geng; Paul Dalhaimer; Shenshen Cai; Richard Tsai; Manorama Tewari; Tamara Minko; Dennis E Discher
Journal: Nat Nanotechnol Date: 2007-03-25 Impact factor: 39.213

Review 3. Drugging the undruggable RAS: Mission possible?

Authors: Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal: Nat Rev Drug Discov Date: 2014-10-17 Impact factor: 84.694

4. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.

Authors: Duy Luong; Prashant Kesharwani; Bryan A Killinger; Anna Moszczynska; Fazlul H Sarkar; Subhash Padhye; Arun K Rishi; Arun K Iyer
Journal: J Colloid Interface Sci Date: 2016-08-24 Impact factor: 8.128

Review 5. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.

Authors: Arpit Bhargava; Neha Bunkar; Naveen Kumar Khare; Dinesh Mishra; Pradyumna Kumar Mishra
Journal: Nanomedicine (Lond) Date: 2014-07 Impact factor: 5.307

6. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.

Authors: Xiaoqian Yang; Arun K Iyer; Amit Singh; Lara Milane; Edwin Choy; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal: Pharm Res Date: 2014-12-17 Impact factor: 4.200

Review 7. The tumor microenvironment and its role in promoting tumor growth.

Authors: T L Whiteside
Journal: Oncogene Date: 2008-10-06 Impact factor: 9.867

Review 8. Receptor-targeted nanocarriers for therapeutic delivery to cancer.

Authors: Bo Yu; Heng Chiat Tai; Weiming Xue; L James Lee; Robert J Lee
Journal: Mol Membr Biol Date: 2010-10 Impact factor: 2.857

9. Expression of CD44 in pancreatic cancer and its significance.

Authors: Xiao-Ping Li; Xiao-Wei Zhang; Lei-Zhen Zheng; Wei-Jian Guo
Journal: Int J Clin Exp Pathol Date: 2015-06-01

10. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.

Authors: Xiaoqian Yang; Arun K Iyer; Amit Singh; Edwin Choy; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal: Sci Rep Date: 2015-02-17 Impact factor: 4.379

5 in total

A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Review 1. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.

2. Shape effects of filaments versus spherical particles in flow and drug delivery.

Review 3. Drugging the undruggable RAS: Mission possible?

4. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.

Review 5. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.

6. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.

Review 7. The tumor microenvironment and its role in promoting tumor growth.

Review 8. Receptor-targeted nanocarriers for therapeutic delivery to cancer.

9. Expression of CD44 in pancreatic cancer and its significance.

10. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.

1. Immunotherapy and molecular role of T-cell in PD-1 antibody treated resectable lung cancer patients.

Review 2. Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems.

3. Fabrication of Ion-Crosslinking Aminochitosan Nanoparticles for Encapsulation and Slow Release of Curcumin.

4. ADAM17 Mediates Hypoxia-Induced Keratinocyte Migration via the p38/MAPK Pathway.

Review 5. Advanced Optical Imaging-Guided Nanotheranostics towards Personalized Cancer Drug Delivery.